Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss…
In recent developments, the once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.…
You Missed
21Shares Debuts First ETF Focused on Canton Network Crypto Token
admin
- Mayıs 9, 2026
- 0 views
Your AI Chatbot May Be Leaking Your Chats to Meta, TikTok and Google
admin
- Mayıs 9, 2026
- 0 views
Blackrock to Launch Tokenized Money-Market Funds on Ethereum
admin
- Mayıs 9, 2026
- 0 views
IMF Warns AI Will Supercharge Cyberattacks on Global Financial System
admin
- Mayıs 9, 2026
- 1 views
